MedPath

MIDOL - CAPLET

MIDOL - CAPLET

Discontinued
DIN Number

02150476

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

bayer inc consumer care

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02150476
AIG Number0311044001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
N02BA51 ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.24
Health Canada Classification

ACTIVE INGREDIENTS (3)

ACETYLSALICYLIC ACIDActive
Strength: 500 MG / TAB
Monograph: ACETYLSALICYLIC ACID
CAFFEINEActive
Strength: 32.4 MG / TAB
Monograph: CAFFEINE
CINNAMEDRINEActive
Strength: 5.5 MG / TAB
Monograph: CINNAMEDRINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.